Perrigo (PRGO) Gross Profit Growth (1y) (2013 - 2026)
Perrigo (PRGO) Gross Profit Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -13.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -13.50% |
| Mar 28, 2026 | -17.03% |
| Dec 31, 2025 | -6.14% |
| Sep 27, 2025 | -6.75% |
| Jun 28, 2025 | -8.06% |
| Mar 29, 2025 | 9.67% |
| Dec 31, 2024 | -9.69% |
| Sep 28, 2024 | -1.65% |
| Jun 29, 2024 | -7.78% |
| Mar 30, 2024 | -13.56% |
| Dec 31, 2023 | 11.68% |
| Sep 30, 2023 | 13.31% |
| Jul 1, 2023 | 15.02% |
| Apr 1, 2023 | 22.50% |
| Dec 31, 2022 | 5.57% |
| Oct 1, 2022 | 7.88% |
| Jul 2, 2022 | 6.62% |
| Apr 2, 2022 | -8.31% |
| Dec 31, 2021 | -22.76% |
| Oct 2, 2021 | -9.01% |